Integra LifeSciences. has filed a patent for a cannula system and method designed for accessing a blood mass in the brain. The system includes a camera mounted on the cannula’s proximal end, allowing surgeons to view the surgical field while minimizing obstruction. The method involves inserting the cannula with an obturator, removing the obturator, and positioning the camera assembly to obtain images of the surgical field through the lumen. GlobalData’s report on Integra LifeSciences gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Integra LifeSciences, was a key innovation area identified from patents. Integra LifeSciences's grant share as of January 2024 was 61%. Grant share is based on the ratio of number of grants to total number of patents.
Cannula system with camera for accessing brain blood mass
See Also:
A recently filed patent (Publication Number: US20230414090A1) outlines a method for accessing and viewing a surgical field within the brain using a cannula system equipped with a camera assembly. The method involves inserting the cannula with an obturator into the patient's brain, removing the obturator to provide access and visibility for the surgical field, and positioning the camera assembly at the proximal end of the cannula to obtain images through the lumen. The images can be transmitted to a display for viewing, and surgical instruments can be passed through the cannula while the camera assembly is in place.
Additionally, the patent claims specify the placement of the prism within the cannula system, with the prism overhanging the lumen by no more than about 15% or 25% of the inside diameter. This design allows for optimal visualization of the surgical field while maintaining space for the passage of surgical instruments. The method outlined in the patent aims to improve the efficiency and accuracy of accessing and viewing the brain's surgical field, potentially enhancing surgical outcomes and patient care in neurosurgical procedures.
To know more about GlobalData’s detailed insights on Integra LifeSciences, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
